MARKET WIRE NEWS
  1. Home
  2. Stock
  3. ANL
  4. News
ANL
Quote
Short
News
Articles
Message Board

Adlai Nortye Ltd. (NASDAQ : ANL ) News

Adlai Nortye Ltd. (NASDAQ: ANL) News Releases

ANL News Releases
ANL : NASDAQ
GlobeNewswire
Adlai Nortye Announces First Patient Enrolled in Global Phase 1 Trial of Pan-RAS (ON) Inhibitor AN9025 for Solid Tumors Harboring RAS Mutations
ANL : NASDAQ
Canada Newswire
Multi-Billion-Dollar VRU Detection Market Unlocking New Growth Opportunities
ANL : NASDAQ
24/7 Market News
Defense wins Super Bowls, AI and Infrastructure Names Drive Today's Playbook
ANL : NASDAQ
SeekingAlpha
Adlai Nortye jumps 25%, raises $140M via private placement
ANL : NASDAQ
GlobeNewswire
Adlai Nortye Announces $140.0 Million Private Placement Equity Financing
ANL : NASDAQ
QM US Market Movers News
US Companies Moving the Markets, Morning edition
Mon, Feb 02, 2026 as of 10.00 am ET
ANL : NASDAQ
QM US Market Movers News
US Companies Moving the Markets, Evening edition
Fri, Jan 30, 2026 as of 4:00 pm ET
ANL : NASDAQ
QM US Market Movers News
US Companies Moving the Markets, Morning edition
Fri, Jan 30, 2026 as of 10.00 am ET
ANL : NASDAQ
QM US Market Movers News
US Companies Moving the Markets, Evening edition
Thu, Jan 29, 2026 as of 4:00 pm ET
ANL : NASDAQ
GlobeNewswire
Adlai Nortye Enters Exclusive License Agreement with ASK Pharm for Pan-RAS (ON) Inhibitor AN9025 in Greater China

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.